ThermoGenesis Holdings, Inc. Common Stock
THMO
THMO was delisted on the 14th of June, 2024.
2 hedge funds and large institutions have $3 invested in ThermoGenesis Holdings, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 15 closing their positions.
88% less funds holding
Funds holding: 17 → 2 (-15)
100% less capital invested
Capital invested by funds: $127K → $3 (-$127K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 15
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$46.4K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$25.3K |
| 3 |
VF
Virtu Financial
New York
|
-$19K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$11.5K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$7.3K |
THMO Hedge Fund Activity: Q2 2024 in Review
2 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in ThermoGenesis Holdings, Inc. Common Stock (THMO) for Q2 2024, worth a combined $3 — down 100% from $127K a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of THMO and 0 opened new positions — a net loss of 15 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Raymond James & Associates, exiting entirely with an estimated $46.4K sold.
- 2 institutional investors held ThermoGenesis Holdings, Inc. Common Stock (THMO) as of Q2 2024, down from 17 in Q1 2024.
- Funds reported $3 of ThermoGenesis Holdings, Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
- 0 funds opened new ThermoGenesis Holdings, Inc. Common Stock positions in Q2 2024 and 15 closed out, a net change of -15 holders.
- The largest ThermoGenesis Holdings, Inc. Common Stock seller in Q2 2024 was Raymond James & Associates, an estimated $46.4K sold.
Based on aggregated 13F filings for Q2 2024.